(IN BRIEF) WACKER and BENEO have launched 2’-Fucosyllactose (2’-FL), a human milk oligosaccharide (HMO), for early-life nutrition. Available initially in Europe, this product is part of a strategic partnership aimed at enhancing the availability of HMOs in the market. The … Read the full press release →
Posted in Business, Chemicals, Environment, Financial, Food & Beverage, Germany, Government, Healthcare, Industrial, Investment, Management, Marketing, News, Science, Technology
Tagged 2’-fucosyllactose, BENEO, biotechnology, Early Life Nutrition, gut microbiota, HMO, Human Milk Oligosaccharides, immune system, infant formula, Market Growth, partnership, prebiotics, Precision Fermentation, strategic partnership, sustainability, WACKER